Movement Alert｜BEIGENE Falls 3.15% in Regular Trading, Biotech Sector Retreats After Strong Monthly Rally

Market Focus07-28 14:34

On July 28, BEIGENE fell 3.15% in regular trading, trading at 193.4 HKD/share, with turnover of 4.41 billion HKD. The decline came amid a broad pullback across the biotechnology sector following an extended rally.

On the news front, the Hang Seng Healthcare Index had accumulated a 17.4% gain over the prior month, significantly outperforming the broader market, intensifying profit-taking pressure. Sector peers declined broadly, with LEADS BIOLABS-B down 8.35%, KEYMED BIO-B down 5.22%, AKESO down 3.55%, and 3SBIO down 1.23%.

At the company level, BEIGENE previously disclosed that a domestic subsidiary is required to pay approximately 446 million RMB in back taxes and late fees, which will be recorded as a current-period expense, weighing on near-term profitability. With the company scheduled to release second-quarter results on August 5, the approaching earnings date combined with significant prior gains has fueled profit-taking sentiment among investors.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1199529859?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-07-28 14:34","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1199529859","market":"us","top_or_hot":-1,"title":"Movement Alert｜BEIGENE Falls 3.15% in Regular Trading, Biotech Sector Retreats After Strong Monthly Rally","media":"Market Focus","content":"<p><p>On July 28, BEIGENE fell 3.15% in regular trading, trading at 193.4 HKD/share, with turnover of 4.41 billion HKD. The decline came amid a broad pullback across the biotechnology sector following an extended rally.</p><p>On the news front, the Hang Seng Healthcare Index had accumulated a 17.4% gain over the prior month, significantly outperforming the broader market, intensifying profit-taking pressure. Sector peers declined broadly, with LEADS BIOLABS-B down 8.35%, KEYMED BIO-B down 5.22%, AKESO down 3.55%, and 3SBIO down 1.23%.</p><p>At the company level, BEIGENE previously disclosed that a domestic subsidiary is required to pay approximately 446 million RMB in back taxes and late fees, which will be recorded as a current-period expense, weighing on near-term profitability. With the company scheduled to release second-quarter results on August 5, the approaching earnings date combined with significant prior gains has fueled profit-taking sentiment among investors.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜BEIGENE Falls 3.15% in Regular Trading, Biotech Sector Retreats After Strong Monthly Rally</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜BEIGENE Falls 3.15% in Regular Trading, Biotech Sector Retreats After Strong Monthly Rally\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-07-28 14:34</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On July 28, BEIGENE fell 3.15% in regular trading, trading at 193.4 HKD/share, with turnover of 4.41 billion HKD. The decline came amid a broad pullback across the biotechnology sector following an extended rally.</p><p>On the news front, the Hang Seng Healthcare Index had accumulated a 17.4% gain over the prior month, significantly outperforming the broader market, intensifying profit-taking pressure. Sector peers declined broadly, with LEADS BIOLABS-B down 8.35%, KEYMED BIO-B down 5.22%, AKESO down 3.55%, and 3SBIO down 1.23%.</p><p>At the company level, BEIGENE previously disclosed that a domestic subsidiary is required to pay approximately 446 million RMB in back taxes and late fees, which will be recorded as a current-period expense, weighing on near-term profitability. With the company scheduled to release second-quarter results on August 5, the approaching earnings date combined with significant prior gains has fueled profit-taking sentiment among investors.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"06160","symbol_name":"百济神州","start_time":0,"source_url":"","article_id":"1199529859","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1199529859","pubTimestamp":1785220480,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On July 28, BEIGENE fell 3.15% in regular trading, trading at 193.4 HKD/share, with turnover of 4.41 billion HKD. The decline came amid a broad pullback across the biotechnology sector following an...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"06160":"百济神州"},"translate_title":"走势警报|百济神州常规交易下跌3.15%，生物技术板块在月度强劲反弹后回落","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"06160":1},"content_text":"On July 28, BEIGENE fell 3.15% in regular trading, trading at 193.4 HKD/share, with turnover of 4.41 billion HKD. The decline came amid a broad pullback across the biotechnology sector following an extended rally.On the news front, the Hang Seng Healthcare Index had accumulated a 17.4% gain over the prior month, significantly outperforming the broader market, intensifying profit-taking pressure. Sector peers declined broadly, with LEADS BIOLABS-B down 8.35%, KEYMED BIO-B down 5.22%, AKESO down 3.55%, and 3SBIO down 1.23%.At the company level, BEIGENE previously disclosed that a domestic subsidiary is required to pay approximately 446 million RMB in back taxes and late fees, which will be recorded as a current-period expense, weighing on near-term profitability. With the company scheduled to release second-quarter results on August 5, the approaching earnings date combined with significant prior gains has fueled profit-taking sentiment among investors.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.46.0","shortVersion":"4.46.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1199529859","isCrawlerRequest":true}